Flavonoids against the SARS-CoV-2 induced inflammatory storm.
Flavonoids against the SARS-CoV-2 induced inflammatory storm.
复制标题
类黄酮抗SARS-CoV-2诱导的炎症风暴。
DOI:
10.1016/j.biopha.2021.111430
复制
发表时间:
2021-06
期刊:
影响因子:
--
通讯作者:
Kubatka P
中科院分区:
文献类型:
--
作者:
Liskova A;Samec M;Koklesova L;Samuel SM;Zhai K;Al-Ishaq RK;Abotaleb M;Nosal V;Kajo K;Ashrafizadeh M;Zarrabi A;Brockmueller A;Shakibaei M;Sabaka P;Mozos I;Ullrich D;Prosecky R;La Rocca G;Caprnda M;Büsselberg D;Rodrigo L;Kruzliak P;Kubatka P
The disease severity of COVID-19, especially in the elderly and patients with co-morbidities, is characterized by hypercytokinemia, an exaggerated immune response associated with an uncontrolled and excessive release of proinflammatory cytokine mediators (cytokine storm). Flavonoids, important secondary metabolites of plants, have long been studied as therapeutic interventions in inflammatory diseases due to their cytokine-modulatory effects. In this review, we discuss the potential role of flavonoids in the modulation of signaling pathways that are crucial for COVID-19 disease, particularly those related to inflammation and immunity. The immunomodulatory ability of flavonoids, carried out by the regulation of inflammatory mediators, the inhibition of endothelial activation, NLRP3 inflammasome, toll-like receptors (TLRs) or bromodomain containing protein 4 (BRD4), and the activation of the nuclear factor erythroid-derived 2-related factor 2 (Nrf2), might be beneficial in regulating the cytokine storm during SARS-CoV-2 infection. Moreover, the ability of flavonoids to inhibit dipeptidyl peptidase 4 (DPP4), neutralize 3-chymotrypsin-like protease (3CLpro) or to affect gut microbiota to maintain immune response, and the dual action of angiotensin-converting enzyme 2 (ACE-2) may potentially also be applied to the exaggerated inflammatory responses induced by SARS-CoV-2. Based on the previously proven effects of flavonoids in other diseases or on the basis of newly published studies associated with COVID-19 (bioinformatics, molecular docking), it is reasonable to assume positive effects of flavonoids on inflammatory changes associated with COVID-19. This review highlights the current state of knowledge of the utility of flavonoids in the management of COVID-19 and also points to the multiple biological effects of flavonoids on signaling pathways associated with the inflammation processes that are deregulated in the pathology induced by SARS-CoV-2. The identification of agents, including naturally occurring substances such as flavonoids, represents great approach potentially utilizable in the management of COVID-19. Although not clinically investigated yet, the applicability of flavonoids against COVID-19 could be a promising strategy due to a broad spectrum of their biological activities.
登录
查看更多内容
影响因子:
2.8
作者:
da Silva FMA;da Silva KPA;de Oliveira LPM;Costa EV;Koolen HH;Pinheiro MLB;de Souza AQL;de Souza ADL
通讯作者:
de Souza ADL
DOI:
10.1007/bf01965393
发表时间:
1982-01-01
期刊:
AGENTS AND ACTIONS
影响因子:
--
作者:
AGARWAL, OP
通讯作者:
AGARWAL, OP
影响因子:
5.9
作者:
Estruel-Amades, Sheila;Massot-Cladera, Malen;Camps-Bossacoma, Mariona
通讯作者:
Camps-Bossacoma, Mariona
影响因子:
3
作者:
Du, Yao;Han, Jibo;Ge, Weihong
通讯作者:
Ge, Weihong
DOI:
10.1016/j.ijbiomac.2020.07.235
发表时间:
2020-12-01
影响因子:
8.2
作者:
Abian, Olga;Ortega-Alarcon, David;Velazquez-Campoy, Adrian
通讯作者:
Velazquez-Campoy, Adrian